Interv Akut Kardiol. 2012;11(1):15-17

Thromboembolism, coagulation and atherothrombosis

Tomáš Kvasnička
Trombotické centrum, ÚKBLD, VFN a 1. LF UK, Praha

The epidemiological and clinical relations between venous thromboembolism and increased incidence of cardiovascular diseases are

intensively studied at present. The classic concept of atherosclerosis indicate a pivotal role of inflammation in the development and

progression of this disease. Atherothrombosis is a disease specific for „a modern“ population and is the most common disease, which

significantly increases mortality and impaires prognosis of the patients. This is a generalized process affecting large and medium size

arteries in a human body. Experimental data indicate that platelets and the coagulation system are important factors of both atherogenesis

and atherothrombosis. Haemostatic system is an important factor in the vascular system, which may influence the molecular

and cellular composition of the arterial wall. The current concept of a vulnerable plaque suggests that repeated plaque microruptures,

followed by subclinical thrombosis, are critical mechanism for plaque growth and vulnerability. In the future, an assessment of the individual

risk, based on molecular genetic approach, may improve the diagnostics and therapeutic effect.

Keywords: atherosclerosis, atherothrombosis, endothelial dysfunction, inflammation, haemostatic system, platelets

Published: January 28, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kvasnička T. Thromboembolism, coagulation and atherothrombosis. Interv Akut Kardiol. 2012;11(1):15-17.
Download citation

References

  1. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003; 348: 1435-1441. Go to original source... Go to PubMed...
  2. Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Tromb Haemost. 2006; 4: 1891-1896. Go to original source... Go to PubMed...
  3. Lowe GD. Common risk factors for both arterial and venous thrombosis. Br J Haematol. 2008; 140: 488-495. Go to original source... Go to PubMed...
  4. Franchini M, Mannucci PM. Venous and arterial thrombosis: different sides of the same Coin? Eur J Intern Med. 2008; 19: 476-481. Go to original source... Go to PubMed...
  5. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006; 367: 651-658. Go to original source... Go to PubMed...
  6. Eitzman DT, Westrick RJ, Shen Y, et al. Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. Circulation 2005; 125: 1822-1825. Go to original source... Go to PubMed...
  7. van der Hagen PB, Folsom AR, Jenny NS, Heckbert SR, O'Meara ES, et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 2006; 259: 1903-1908. Go to original source... Go to PubMed...
  8. Ahlehoff O, Gislasson GH, Torp-Pedersen C, Hansen PR. Risk assessment for recurrent venous thrombosis. Lancet. 2011; 377: 1073-1074. Go to original source... Go to PubMed...
  9. Jezovnik MK, Poredos P. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol. 2010; 29: 226-231. Go to PubMed...
  10. Ageno W, Prandoni P, Romualdi E, et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006; 4: 1914-1918. Go to original source... Go to PubMed...
  11. Folsom AR, Ohira T, Yamagishi K, Cushman M. Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost 2009; 7: 1774-1778. Go to original source... Go to PubMed...
  12. Katrancioglu N, et al. Association Between ApoE4 Allele and Deep Venous Thrombosis: A pilot Study, Clin and Apl. Thrombosis/Haemostasis, 2009; 17: 225-228. Go to original source... Go to PubMed...
  13. Massberg S, Brand K, Gruner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002; 196: 887-896. Go to original source... Go to PubMed...
  14. Huo I, Schober A, Forlow SB, et al. Circulating activated platelets exacerbace atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003; 9: 61-67. Go to original source... Go to PubMed...
  15. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005; 115: 3378-3384. Go to original source... Go to PubMed...
  16. Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Cirk Res. 2005; 96: 612-616. Go to original source... Go to PubMed...
  17. Semple JW, Italiano JE jr, Freedman J. Platelets and the immune continuum. Nat Rew Immunol. 2011; 11: 264-274. Go to original source... Go to PubMed...
  18. Fontana P, Dupont A, Gandrille S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003; 108: 989-995. Go to original source... Go to PubMed...
  19. Kvasnička J, Hájková J, Bobčíková P, Dušková D, Poletínová P, Kieferová V, Pecen L. Polymorfismy genu krevních desticek spojovaných s aterotrombogenezí a jejich výskyt ve zdravé české populaci středního věku. Co ret Vasa, 2009; 51: 187-193. Go to original source...
  20. Borissoff Jl, Heeneman S, Kilinc E, et al. Early atherosclerosis exhibits an enhanced procoagulant state. Circulation, 2010; 122: 821-830. Go to original source... Go to PubMed...
  21. Kramer MC, Rittersma SZ, de Winter RJ, et al. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol. 2010; 55: 122-132. Go to original source... Go to PubMed...
  22. Ardissino D, Merlini PA, Ariens R, Coppola R, Bramucci E, et al. Tissue factor antigen and activity in human coronary atherosclerotic plaques. Lancet, 1997; 349: 769-771. Go to original source... Go to PubMed...
  23. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006; 367: 651-658. Go to original source... Go to PubMed...
  24. Borensztajn K, Peppelenbosch MP, Spek CA. Factor Xa: at the crossroads between coagulation and signaling in fysiology and disease. Trends Mol Med., 2008; 14: 429-440. Go to original source... Go to PubMed...
  25. Thomas AC, Campbell JH. Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosis. Atherosclerosis, 2004; 176: 73-81. Go to original source... Go to PubMed...
  26. Borissoff JI, Spronk HM, Heeneman S, et al. Is thrombin a key player in the, ,coagulation-atherogenesis" maze? Cardiovasc Res. 2009; 82: 392-403. Go to original source... Go to PubMed...
  27. Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation path-way. Nat Med. 2006; 12: 682-687. Go to original source... Go to PubMed...
  28. Folsom AR, Wu KK, Rosamond WD, et al. Prospective study of hemostatik factors and incidence of coronary heart dinase: the ARIC study. Circulation, 1997; 96: 1102-1108. Go to original source... Go to PubMed...
  29. Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of cardiovascular diseases and nonvalvular mortality: an individual participant mataanalysis. Jama, 2005; 294: 1799-1809. Go to original source... Go to PubMed...
  30. de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Haemost. 2010; 8: 489-495. Go to original source... Go to PubMed...
  31. Folsom AR. Hemostatic risk factors for atherothrombotic dinase: an epidemiologic view. Thromb Haemost, 2001; 86: 366-373. Go to original source... Go to PubMed...
  32. Degryse B, Neels JG, Czekay RP, Aertgeerts K, Kamikubo Y, et al. The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. J Biol Chem. 2004; 279: 595-604. Go to original source... Go to PubMed...
  33. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008; 117: 93-102. Go to original source... Go to PubMed...
  34. Monroe DM, Key NS. The tissue Factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost. 2007; 5: 1097-1105. Go to original source... Go to PubMed...
  35. Di Tullio MR, Homma S, Jin Z, Sacco RL. Aortic atherosclerosis, hypercoagulation and stroke the APRIS (Aortic Plaque and Risk of lschemic stroke) study. J Am Coll Cardiol. 2008; 52: 855-861. Go to original source... Go to PubMed...
  36. Randi AM, Biguzzi E, Falciani F, et al. Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis.J Thromb Haemost. 2003; 1: 829-835. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.